Daxx Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-56136
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Immunoblotting, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Product Specifications
Immunogen
A synthetic peptide corresponding to amino acids 272-291 (ERLINKPGPDTFPDYGDVLR, GenBank no. gi/62898369) of human DAXX was used as immuogen.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Daxx Antibody
Immunohistochemistry-Paraffin: Daxx Antibody [NB100-56136]
Immunohistochemistry-Paraffin: Daxx Antibody - Unpurified [NB100-56136] - Daxx Antibody [NB100-56136] - Tissue sections of human prostate cancer (A and B) stained for Daxx expression using this antibody at 1:2000. Hematoxylin-eosin counterstain.Applications for Daxx Antibody
Application
Recommended Usage
Immunoblotting
reported in scientific literature (PMID 28501693)
Immunohistochemistry-Paraffin
1:1000-1:5000
Immunoprecipitation
1:50-1:200
Western Blot
1:1000-1:2000
Formulation, Preparation, and Storage
Purification
Unpurified
Formulation
Whole antisera
Preservative
0.05% Sodium Azide
Concentration
This product is unpurified. The exact concentration of antibody is not quantifiable.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Daxx
Long Name
Fas Death Domain-associated Protein
Alternate Names
BING2, DAP6
Gene Symbol
DAXX
Additional Daxx Products
Product Documents for Daxx Antibody
Product Specific Notices for Daxx Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...